Associate Professor, Amsterdam UMC (NL)
Dr. Leemhuis earned his Ph.D. in 1996 from the University of Amsterdam, with a thesis focused on "Thyroxine Supplementation in Very Preterm Infants." His research has had a profound impact on the care of premature infants and the long-term developmental outcomes of neonates.
Since October 1, 1996, Dr. Leemhuis has been a faculty member in the Department of Pediatrics, Division of Neonatology, at the Emma Children's Hospital, Amsterdam University Medical Center. He has served as Associate Professor since 2000 and as the head of the outpatient follow-up clinic for NICU graduates. His leadership extends to national and international roles, including serving as Chair of the Dutch Society of Follow-Up of NICU Graduates from 2003 to 2013. From 2005 to 2013, he was also an Adjunct Professor of Pediatrics at New York Medical College. Since 2014, Dr. Leemhuis has been a consultant to the Expertise Center for Post-discharge Developmental Support (EOP-Nl), specializing in the development of premature infants post-discharge.
Dr. Leemhuis has played a key role in shaping clinical guidelines at both the national and European levels. He contributed to the development of the Dutch guideline on aftercare for preterm and small-for-date neonates, a collaborative effort between preventive primary healthcare, the Dutch Society of Pediatrics, and the Dutch Association of Parents of Preterm Infants. He also serves as co-chair of the Follow-Up and Continuing Care Topic Expert Group for the European Foundation for the Care of Neonates and Infants (EFCNI) and is a member of its Scientific Advisory Board.
Outside of his professional career, Dr. Leemhuis is dedicated to philanthropic endeavors. He is the chair of the Fundatie van den Santheuvel, Sobbe, a foundation that supports social projects in the Netherlands.
Dr. Leemhuis’s research focuses on several critical areas, including developmental outcomes in premature infants, developmental care after discharge, and child follow-up for conditions such as fetal growth restriction. His work also investigates the relationship between thyroid function and premature birth. His research aims to prevent neurodevelopmental disabilities in children from 0 to 13 years of age, with a focus on primary, secondary, and tertiary prevention. Dr. Leemhuis’s research has received funding from a wide range of sources, including hospital-based institutes and the US-based National Institutes of Health (NIH).
Dr. Leemhuis’s contributions to neonatology, developmental care, and child follow-up are foundational to improving outcomes for premature infants and have earned him recognition as a leader in his field.
Need assistance? We're here to help!
Visit our Help Center |